跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
查看斯高帕斯 (Scopus) 概要
陳 志彥
教授
醫學系內科學科
電子郵件
chency
vghtpe.gov
tw
h-index
h10-index
h5-index
3231
引文
29
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
398
引文
12
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
78
引文
4
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1995 …
2026
每年研究成果
概覽
指紋
網路
研究成果
(137)
類似的個人檔案
(6)
指紋
查看啟用 Chih-Yen Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Des-acyl Ghrelin
100%
Ghrelin
73%
Sleeve Gastrectomy
56%
Stomach
52%
Obestatin
49%
Gastric Emptying
48%
Gastric Bypass
46%
Type 2 Diabetes Mellitus (T2DM)
44%
Gastrointestinal Motility
42%
Food Intake
39%
Conscious Rat
35%
Helicobacter Pylori (H. pylori)
35%
Taiwan
30%
Colonic Secretion
29%
Metabolic Surgery
28%
Irritable Bowel Syndrome
28%
Gut Hormones
28%
Gut Motility
28%
Type 2 Diabetic Patients
27%
Gastrointestinal Transit
26%
Duodenum
25%
After Surgery
24%
Bariatric Surgery
23%
Gastrointestinal Tract
22%
Colonic Motility
21%
Slow Waves
20%
Risk Factors
20%
Antrum
20%
Motility
19%
Duodenal Ulcer
19%
Total Gastrectomy
19%
Body Mass Index
19%
Small Bowel Transit
18%
Plasma Parameters
18%
Omeprazole
17%
Chinese Population
17%
Social Impact
17%
Hepatocellular Carcinoma
17%
Corticotropin-releasing Hormone Receptor 2
17%
Oriental Studies
17%
Dominant Frequency
17%
Power Ratio
16%
Fed State
16%
2 Receptor
16%
Rheumatoid Arthritis
15%
Urocortin
15%
Colonic Transit Time
15%
Gene Products
15%
Gastric Sleeve
15%
Remitters
15%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
71%
Sleeve Gastrectomy
60%
Gastric Bypass
51%
Gastric Bypass Surgery
51%
Ghrelin
39%
Stomach
34%
Patient with Type 2 Diabetes
32%
Bariatric Surgery
31%
Gastrointestinal Motility
27%
Gastrointestinal Hormone
24%
Irritable Bowel Syndrome
24%
Hepatocellular Carcinoma
23%
Glucose
22%
Body Mass Index
21%
Stomach Emptying
21%
Gastrectomy
19%
Injection
19%
Obestatin
18%
Gut
18%
Colonic Secretion
18%
Helicobacter Pylori
17%
Diabetes
16%
Electrogastrogram
16%
Bleeding
15%
Gastrointestinal Transit
14%
Sphincter
14%
Colon Motility
14%
Food Intake
12%
Oral
12%
Jejunum Ulcer
12%
Gastrointestinal Tract
12%
Prevalence
11%
Acute Pancreatitis
11%
Abdominal Cancer
11%
Insulin Release
11%
Lower Gastrointestinal Bleeding
11%
Pancreas Polypeptide
11%
Vasoactive Intestinal Polypeptide
11%
functional dyspepsia
11%
Fibroblast Growth Factor 19
11%
Diabetic Obesity
11%
Nonalcoholic Fatty Liver
11%
Constipation
10%
Oral Glucose Tolerance Test
10%
Bile Acid
10%
Rhythm
10%
Hepatitis B Virus
10%
Duodenum
10%
Colon
10%
Total Stomach Resection
9%
Pharmacology, Toxicology and Pharmaceutical Science
Ghrelin
82%
Rat
72%
Irritable Colon
23%
Helicobacter Pylori
22%
Obestatin
21%
Duodenum Ulcer
18%
Peptide
17%
Omeprazole
14%
Diarrhea
13%
Endothelin 1
13%
Receptor
12%
Gastrointestinal Hormone
11%
Corticotropin Releasing Factor
11%
Adverse Event
9%
Normal Human
9%
Hydrogen
7%
Corticosteroid
7%
Corticotropin Releasing Factor Receptor 2
7%
Glucose
7%
Nitrite
7%
Diseases
7%
Liver Disease
7%
Heartburn
7%
Intermedin
7%
Polyp
7%
Cachexia
6%
Urocortin III
6%
Jejunum Ulcer
6%
Peptic Ulcer
6%
Clinical Trial
6%
Steroids
6%
Non-Steroidal Anti-Inflammatory Drug
6%
Octanoic Acid
6%
Liver Cirrhosis
6%
Maturity Onset Diabetes of the Young
6%
Ulcer Healing
6%
Hepatitis B Virus
5%
Fatty Liver
5%
Rheumatoid Arthritis
5%
Etanercept
5%
Pancreas Polypeptide
5%
Cholelithiasis
5%
Inflammatory Arthritis
5%
Dexamethasone
5%
Muscle Injury
5%
Intestinal Dysmotility
5%
Methylprednisolone
5%
Systemic Lupus Erythematosus
5%
Antioxidant
5%
Endocannabinoid
5%
